This guide offers an educational, technical overview of oncology ablation and the device technologies used in this field. Beyond needle-based approaches, focused laser energy delivered through endoscopic instruments can be used trans-urethrally to vaporize or coagulate bladder tumors and to treat benign prostatic hyperplasia (BPH) with the aim of limiting bleeding. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Percutaneous Tumor Ablation
RFA has an extensive track record in hepatocellular carcinoma (HCC), MWA is frequently applied to liver and lung tumors, and cryoablation is often described for renal cell carcinoma, though indications are always defined by the treating team. Beyond needle-based approaches, focused laser energy delivered through endoscopic instruments can be used trans-urethrally to vaporize or coagulate bladder tumors and to treat benign prostatic hyperplasia (BPH) with the aim of limiting bleeding. Intracavitary hypothermia describes controlled temperature therapy delivered directly into a body cavity such as the bladder, and is generally positioned as an adjunct intended to enhance the penetration of intravesical chemotherapy.
Core Technologies and Options
Microwave Ablation (MWA) Systems. Microwave ablation generates an oscillating electromagnetic field at the antenna tip that agitates water molecules, producing frictional heat that can create a cytotoxic ablation zone in seconds to minutes. Compared with radiofrequency energy, microwave energy is often described in the literature as less susceptible to tissue charring and to the heat-sink effect near larger vessels, which may support more uniform heating. Radiofrequency Ablation (RFA) for Liver Tumors. Radiofrequency ablation passes a high-frequency alternating current from an electrode into surrounding tissue, where ionic agitation generates resistive heat that is intended to coagulate a targeted tumor volume. For hepatocellular carcinoma, RFA is one of the most studied thermal techniques and is commonly performed under ultrasound or CT guidance in appropriately selected patients. Percutaneous Thermal Ablation Electrodes. Percutaneous thermal ablation relies on an applicator advanced through the skin to the tumor under imaging, so that energy is confined as much as possible to the target while sparing adjacent structures. Electrode and antenna design, including cooling features and active-tip geometry, is intended to shape the resulting ablation zone and manage temperature at the applicator interface. Intraosseous Ablation for Spinal Tumors. Intraosseous ablation delivers energy directly into bone to target vertebral or spinal tumors, an environment that differs from soft tissue because of the dense, mineralized matrix involved. Radiofrequency energy can be used to coagulate tumor tissue within the vertebral body, and it is sometimes combined with cement augmentation as decided by the treating team. Laser Trans-Urethral Ablation. Laser trans-urethral ablation uses focused laser energy delivered through endoscopic instruments to vaporize or coagulate tissue from within the urinary tract without an external incision. In the bladder it may be applied to ablate tumor tissue, and in BPH it is used to reduce obstructing prostatic tissue with the stated aim of limiting bleeding during the procedure. Intracavitary Hypothermia for Bladder Cancer. Intracavitary hypothermia delivers controlled temperature therapy directly into the bladder, and is generally described as an adjunct intended to enhance the penetration and effect of intravesical chemotherapy rather than as a standalone ablation. By modulating the local temperature of the bladder wall and instilled agent, the approach is designed to support drug delivery to the urothelium in appropriately selected patients.
Comparing the Approaches
Microwave ablation (MWA) vs Radiofrequency ablation (RFA). Both microwave and radiofrequency ablation are heat-based techniques that aim to coagulate a tumor in place, and both are widely used percutaneously under image guidance. RFA systems typically rely on tissue impedance and electrode cooling, whereas MWA depends on antenna and generator characteristics, so the practical trade-offs differ by lesion. Ablation vs Surgical resection. Ablation destroys a tumor in situ through a needle-like applicator, while surgical resection physically removes the tumor and a margin of surrounding tissue. Resection remains a well-established option for many tumors and can provide a specimen for pathological margin assessment, which ablation does not. Cryoablation vs Microwave ablation. Cryoablation uses lethal cold and produces an ice ball that is often visible on imaging, whereas microwave ablation uses heat and generally creates its zone more rapidly. Each carries its own considerations, such as bleeding risk profiles and effects near vessels, which are weighed per patient.
INVAMED Portfolio in This Area
INVAMED's related devices include: HyperTiss Intracavitary Hypothermia Set for Bladder Cancer Treatment, Fusion Intraosseous Radiofrequency Ablation System for Spinal Tumors, Peta Radiofrequency Ablation, ThermoEdge RFA Platform. Detailed specifications for each are provided in the product documentation.
Key Considerations
- Achieving an adequate ablation margin is widely emphasized in the literature for durable local tumor control, and may call for overlapping applications in larger lesions.
- For lesions near large vessels, the heat-sink effect can influence the completeness of heat-based ablation and is factored into planning.
- Image guidance with ultrasound, CT, or other modalities supports accurate applicator placement and monitoring of the treatment zone.
Frequently Asked Questions
Is the HyperTiss set an ablation device?
INVAMED describes HyperTiss as an intracavitary (intravesical) temperature-therapy set intended for adjunctive use with intravesical chemotherapy in bladder cancer, rather than as a standalone tumor ablation device.
Does ablation replace surgery?
Not necessarily; ablation is a local, minimally invasive option that may be considered instead of or alongside surgery in appropriately selected patients, and the decision is made within a multidisciplinary team.
What determines the ablation zone size?
Published sources note that factors such as generator power, applicator design, application time, and local blood flow influence the ablation zone, and settings are selected by the treating physician.
About INVAMED
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Related on INVAMED
- Oncology Ablation — product category
- Microwave ablation (MWA) vs Radiofrequency ablation (RFA): What Is the Difference?
- Sourcing Oncology Ablation Devices: A Manufacturer and Procurement Guide
- How long is recovery after tumor ablation?
Important Disclaimer
The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.